ZA795679B - Intramammary compositions - Google Patents
Intramammary compositionsInfo
- Publication number
- ZA795679B ZA795679B ZA00795679A ZA795679A ZA795679B ZA 795679 B ZA795679 B ZA 795679B ZA 00795679 A ZA00795679 A ZA 00795679A ZA 795679 A ZA795679 A ZA 795679A ZA 795679 B ZA795679 B ZA 795679B
- Authority
- ZA
- South Africa
- Prior art keywords
- intramammary
- compositions
- intramammary compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7842336 | 1978-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA795679B true ZA795679B (en) | 1980-10-29 |
Family
ID=10500661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00795679A ZA795679B (en) | 1978-10-27 | 1979-10-24 | Intramammary compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US4282202A (enExample) |
| EP (1) | EP0010904B1 (enExample) |
| JP (1) | JPS5559108A (enExample) |
| AU (1) | AU524193B2 (enExample) |
| CA (1) | CA1121724A (enExample) |
| DE (1) | DE2962727D1 (enExample) |
| IE (1) | IE48976B1 (enExample) |
| IL (1) | IL58461A0 (enExample) |
| NZ (1) | NZ191910A (enExample) |
| ZA (1) | ZA795679B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
| DE3266580D1 (en) * | 1981-12-02 | 1985-10-31 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
| GB2119649B (en) * | 1982-05-12 | 1986-02-12 | Beecham Group Plc | Ophthalmic cloxacillin compositions |
| GB8629481D0 (en) * | 1986-12-10 | 1987-01-21 | Beecham Group Plc | Veterinary treatment |
| GB9007143D0 (en) * | 1990-03-30 | 1990-05-30 | Beecham Group Plc | Veterinary composition |
| US5643902A (en) * | 1990-04-26 | 1997-07-01 | Pfizer Inc. | Veterinary treatment |
| GB9009446D0 (en) * | 1990-04-26 | 1990-06-20 | Beecham Group Plc | Veterinary composition |
| SI9200139A (en) * | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
| US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
| PT862431E (pt) * | 1995-09-07 | 2002-04-29 | Smithkline Beecham Plc | Utilizacao de uma formulacao farmaceutica pediatrica que compreende amoxicilina e clavulanato |
| US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
| GB9818927D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Pharmaceutical formulation |
| DE60003255T2 (de) * | 1999-04-13 | 2004-05-06 | Beecham Pharmaceuticals (Pte) Ltd. | Neue Behandlungsmethode unter Verwendung einer hochdosierten Form von Amoxycillin und Kaliumclavulanat |
| US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
| DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
| WO2006077856A1 (ja) * | 2005-01-19 | 2006-07-27 | Nippon Zenyaku Kogyo Co., Ltd. | 乳房炎用注入剤 |
| EP2066302A2 (en) * | 2006-09-26 | 2009-06-10 | Taro Pharmaceuticals North America, Inc. | Stabilizing compositions for antibiotics and methods of use |
| CN101406450B (zh) * | 2007-10-12 | 2010-08-25 | 河南农业大学 | 复方阿莫西林油混悬注射液制备工艺 |
| WO2009120885A2 (en) * | 2008-03-26 | 2009-10-01 | Taro Pharmaceuticals U.S.A., Inc. | Stabilizing lipid compositions for oral pharmaceutical agents |
| HRP20191412T1 (hr) | 2012-02-27 | 2019-11-15 | Bayer New Zealand Ltd | Pripravci s kontroliranim oslobađanjem i postupci njihove upotrebe |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2914443A (en) * | 1958-03-31 | 1959-11-24 | Abbott Lab | Ointment |
| CA758049A (en) * | 1960-07-19 | 1967-05-02 | The Gillette Company | Heat-generating cosmetic composition |
| US3234028A (en) * | 1961-09-20 | 1966-02-08 | Union Carbide Corp | Process for banana ripening |
| US3302995A (en) * | 1963-05-01 | 1967-02-07 | Thomas D Oulton | Synthetic swelling lithium aluminum silicate hydrate product |
| US4000254A (en) * | 1966-04-25 | 1976-12-28 | Schmid Laboratories, Inc. | Fungimycin compositions |
| US4064230A (en) * | 1966-04-25 | 1977-12-20 | Schmid Laboratories, Inc. | Polyenic macrolide compositions |
| US3733403A (en) * | 1970-01-26 | 1973-05-15 | Squibb & Sons Inc | Gelled mineral oil |
| GB1508977A (en) * | 1974-04-20 | 1978-04-26 | Beecham Group Ltd | Beta-lactam antibiotic from streptomyces clavuligerus |
| GB1455296A (en) * | 1973-05-24 | 1976-11-10 | Beecham Group Ltd | Veterinary treatment |
| US3923969A (en) * | 1973-06-12 | 1975-12-02 | Battelle Institut E V | Carrier system for a drug with sustained release |
| US4145429A (en) * | 1974-09-21 | 1979-03-20 | Beecham Group Limited | Oral veterinary preparations |
| US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
| US3998973A (en) * | 1975-04-07 | 1976-12-21 | R. T. Vanderbilt Company, Inc. | Thickening composition |
| US4071374A (en) * | 1975-06-23 | 1978-01-31 | Gripsin Industries, Inc. | Friction cosmetic gel |
| GB1547164A (en) * | 1975-08-14 | 1979-06-06 | Beecham Group Ltd | Veterinary compositions |
| GB1561592A (en) * | 1976-05-05 | 1980-02-27 | Beecham Group Ltd | Antibacterial composition |
| JPS5325005A (en) * | 1976-08-19 | 1978-03-08 | Marutai Doboku Kk | Method of driving steellpipe pile |
| DE2654709C3 (de) * | 1976-12-02 | 1987-07-09 | A. H. Robins Co. Inc., Richmond, Va. | Verfahren zum Stabilisieren von Baldrianextraktpräparaten |
-
1979
- 1979-10-16 IL IL58461A patent/IL58461A0/xx unknown
- 1979-10-18 DE DE7979302254T patent/DE2962727D1/de not_active Expired
- 1979-10-18 EP EP79302254A patent/EP0010904B1/en not_active Expired
- 1979-10-22 AU AU52008/79A patent/AU524193B2/en not_active Expired
- 1979-10-24 NZ NZ191910A patent/NZ191910A/xx unknown
- 1979-10-24 ZA ZA00795679A patent/ZA795679B/xx unknown
- 1979-10-26 CA CA000338545A patent/CA1121724A/en not_active Expired
- 1979-10-26 JP JP13860579A patent/JPS5559108A/ja active Granted
- 1979-10-26 IE IE2061/79A patent/IE48976B1/en not_active IP Right Cessation
- 1979-10-29 US US06/088,859 patent/US4282202A/en not_active Ceased
-
1982
- 1982-02-03 US US06/345,474 patent/USRE31301E/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5559108A (en) | 1980-05-02 |
| EP0010904B1 (en) | 1982-05-05 |
| CA1121724A (en) | 1982-04-13 |
| EP0010904A3 (en) | 1980-07-23 |
| US4282202A (en) | 1981-08-04 |
| AU524193B2 (en) | 1982-09-02 |
| JPH0223530B2 (enExample) | 1990-05-24 |
| AU5200879A (en) | 1980-05-01 |
| USRE31301E (en) | 1983-07-05 |
| IE48976B1 (en) | 1985-06-26 |
| EP0010904A2 (en) | 1980-05-14 |
| DE2962727D1 (en) | 1982-06-24 |
| IL58461A0 (en) | 1980-01-31 |
| NZ191910A (en) | 1982-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS54155292A (en) | Photoopolymerizable composition | |
| JPS5571734A (en) | Composition | |
| JPS5523187A (en) | Photoohardening composition | |
| JPS54158452A (en) | Composition | |
| JPS54109654A (en) | Improvement regarding composition | |
| JPS5580451A (en) | Composition | |
| ZA795679B (en) | Intramammary compositions | |
| JPS54139654A (en) | Composition | |
| JPS5571653A (en) | Cement based composition | |
| GB2021610B (en) | Antianginal composition | |
| JPS5523186A (en) | Photoohardening composition | |
| ZA795680B (en) | Intramammary compositions | |
| JPS54152038A (en) | Flameeproof*lowwsmoke hottmelt composition | |
| JPS54107993A (en) | Alphaacyanoacrylate composition | |
| JPS54147931A (en) | Antiiulcer composition | |
| JPS54122228A (en) | Novel composition | |
| KE3426A (en) | Etomidate-containing compositions | |
| GR64830B (en) | Disinfectaut composition | |
| PT69935A (en) | Insecticidals compositions | |
| GB2020267B (en) | Cement composition | |
| JPS54116026A (en) | Cement composition | |
| JPS54147934A (en) | Antiiangina composition | |
| PT69225A (en) | Compositions | |
| ZA793302B (en) | Fasciolicidal compositions | |
| PT70100A (en) | Farmaceutical compositions |